The abstract is read at the publisher; the summary is JClub's.
CanVar-UK is a freely accessible platform that supports germline cancer susceptibility gene variant interpretation using data for over 1.1 million coding SNVs across 116 established CSGs.
- Why it matters: Consistent classification is critical when cascade testing spreads families across geographies and requires sharing variant and clinical information between genomic centers.
- What they did: The platform integrates annotations including in silico scores from 11 tools, gnomAD v4.1 allele frequencies, case counts from multiple cohorts, functional/splicing readouts from 47 datasets across 19 CSGs, and live ClinVar consensus linkage.
- The result: NHS diagnostic scientists in the UK already use CanVar-UK, with a growing international registered base (>800 UK and >600 non-UK users) and forum-captured real-time discussions and classifications.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.